<DOC>
	<DOC>NCT01694758</DOC>
	<brief_summary>OPTIMISE-CEEMEA is a multinational, multi-centre, observational, prospective study which will include patients suffering from diabetes type 2, treated or untreated, insulin dependent or not insulin dependent. In this study we aim to explore at a primary care level whether the use of benchmarking against a set of guideline-based reference values on a patient basis, may improve quality of patient care, in particular control of diabetes, lipids and blood pressure.</brief_summary>
	<brief_title>OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Subjects suffering from diabetes type 2, treated or untreated, insulin dependent or not insulin dependent Able to read and send SMS (if SMS applicable) Type 1 diabetes Pregnancy diabetes Hospitalization at the moment of enrollment in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Benchmarking could improve quality of patient care</keyword>
	<keyword>ESC and ATP III Guidelines</keyword>
</DOC>